Today: 30 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor (OPEN) Stock Today: Price, News, Warrant Dividend and Outlook – November 20, 2025

Opendoor Technologies shares fell 8% to $6.16 Thursday on heavy volume after a week of sharp declines, despite being up over 300% year-to-date. The company will issue three series of tradable warrants to shareholders on November 21. Fresh housing data showing a stalled U.S. market has renewed concerns about Opendoor’s inventory-heavy model. Q3 revenue beat forecasts, but the firm posted a $90 million net loss.
20 November 2025
··
Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings shares fell 16% to $6.27 in late trading Thursday after a $35 million investment in combat drone maker PDW and a shareholder vote doubling authorized shares to 800 million. Volume surged to 114 million shares as ONDS swung between $6.25 and $7.98. The company reported Q3 revenue up 582% year over year but remains unprofitable.
20 November 2025
··
JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY shares jumped over 6% Thursday, trading near $63.70 after the company posted Q3 2025 results, raised its dividend, and issued stronger revenue guidance. Net revenue rose 6.4% sequentially to $540.2 million, though still down from last year. Trading volume topped 1.2 million shares. JOYY stock is up more than 50% year-to-date and near its 52-week high.
20 November 2025
··
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax shares surged 8% to $121.94 Thursday afternoon on heavy volume after fresh takeover rumors involving AstraZeneca. The French biotech’s stock is up about 1,450% year-to-date, fueled by strong Phase 3 ulcerative colitis data and M&A speculation. No deal has been confirmed by either company. Intraday volume reached 3.75 million ADSs, far above recent averages.
20 November 2025
··
Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

KLIC shares jumped 11% to around $39.23 Thursday after Kulicke & Soffa posted better-than-expected Q4 earnings and raised its outlook for early fiscal 2026. Volume neared 900,000 shares by early afternoon. Q4 revenue reached $177.6 million, down 2% year over year but up 20% sequentially. The move follows a 12% after-hours surge Wednesday after the company beat Wall Street estimates.
20 November 2025
1 … 725 726 727

Stock Market Today

  • Markets Slide as Crude Oil Surges Above $100 Amid Middle East Tensions
    March 30, 2026, 4:14 PM EDT. U.S. stock indexes fell with the S&P 500 down 0.75%, Dow Jones off 0.21%, and Nasdaq 100 dropping 1.18%. The selloff followed crude oil prices surging over 2% to above $100 a barrel-the first settlement above this level since 2022. The spike was driven by heightened supply risks as Iranian attacks disrupt shipping through the Strait of Hormuz, a crucial oil transit route. Goldman Sachs warned oil could surpass its 2008 peak near $150 if disruptions persist. Treasury yields declined amid Federal Reserve Chair Jerome Powell's remarks on limited policy tools against supply shocks. The market priced just a 3% chance of an interest rate hike next month. Overseas, European and Chinese equities edged higher, while Japan's Nikkei dropped nearly 3% to a three-month low amid geopolitical strains.
Go toTop